Pharmacokinetic Interactions of Quadruple Therapy With Anaprazole/Amoxicilin/Clarithromycin/Bismuth
Status:
Not yet recruiting
Trial end date:
2020-10-15
Target enrollment:
Participant gender:
Summary
A single-center, randomized, open-label, crossover study to evaluate the pharmacokinetic
drug-drug interaction and safety of the quadruple therapy with Anaprazole 20mg/Amoxicilin
1000mg/Clarithromycin 500mg/Bismuth Potassium Citrate 0.6g in healthy Chinese male subjects.